
Dr. Oz tells states not to use Medicaid money on gender-affirming care for children
The new head of the Centers for Medicare & Medicaid Services says states shouldn’t use Medicaid money for surgeries or hormone treatments in minors.
In one of his first messages since becoming director of the Centers for Medicare & Medicaid Services, Dr. Mehmet Oz is telling states that Medicaid funds are not to be used for gender-affirming care for children.
In a
“CMS will not support services that violate this standard or place vulnerable children at risk. It is a CMS responsibility to steward Medicaid dollars and ensure resources focus on protecting our most vulnerable,” Oz said.
Psychotherapy should be “the first line of treatment,” Oz said.
“This isn’t about politics or stigma,” Oz said in the statement. “It’s about protecting people from decisions they may not fully understand, and consequences they can’t undo.”
The CMS sent a
The CMS directive probably shouldn’t come as a shock to states or health systems. Shortly after returning to the White House in January,
The
The American Medical Association has also urged governors to block state laws that would prohibit gender-affirming care.
“Decisions about medical care belong within the sanctity of the patient-physician relationship,” the AMA wrote in
Many efforts to prohibit gender-affirming care to minors are playing out at the state level, with states passing measures to prohibit such treatment.
More than half of the states have passed measures prohibiting gender-affirming care, and nearly 40% of the nation’s transgender youth between the ages of 13 and 17 are living in states that have passed bans on gender-affirming care, according to
Liana Douillet Guzmán, CEO of FOLX Health, a digital health service provider offering care for LGBTQIA+ patients, told Chief Healthcare Executive® in
The Senate voted
A heart surgeon, Oz gained fame through appearances on Oprah Winfrey’s show and hosted his own long-running daytime talk show for years.
Hospitals and healthcare leaders have been pressing the Trump administration and Congress








































